Tevido Biodevices LLC is categorized under Surgical Appliances Manufacturers in Austin, TX and active since 2011.
Tevido Biodevices LLC was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Surgical Appliances Manufacturers business, which does work in the B2B market, and is classified as a Surgical Appliances Manufacturers, under code number 339113 by the NAICS.
If you are seeking more information, feel free to contact Laura Bosworth-Bucher at the company’s single location by writing to 12004 Hispania Court, Austin, Texas TX 78727 or by phoning (512) 828-2596. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Tevido Biodevices LLC |
| Contact Person: | Laura Bosworth-Bucher |
| Address: | 12004 Hispania Court, Austin, Texas 78727 |
| Phone Number: | (512) 828-2596 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Surgical Appliances Manufacturers |
| SIC Code: | 3842 |
| NAICS Code: | 339113 |
| Share This Business: |
Tevido Biodevices LLC was started in 2011 to provide professional Surgical Appliances Manufacturers under the SIC code 3842 and NAICS code 339113. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Laura Bosworth-Bucher for inquiries that concern Tevido Biodevices LLC by calling the company number (512) 828-2596, as your correspondence is most welcome. Additionally, the physical location of the single location of Tevido Biodevices LLC can be found at the coordinates 30.418381,-97.730472 as well as the street address 12004 Hispania Court in Austin, Texas 78727.
For its online presence, you may visit Tevido Biodevices LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.